6 ms·
FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer
- jfengel 5y ago> Median survival was 13.8 months for patients who received Opdivo plus chemotherapy compared to 11.6 months for patients who received chemotherapy alone. Oof. It's great that they've found something that is promising, but clearly we've still got a long way to go.